Literature DB >> 141323

A structure-activity analysis of chemical and biological parameters of chloroethylnitrosoureas in mice.

L C Panasci, D Green, R Nagourney, P Fox, P S Schein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 141323

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  16 in total

1.  Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin. I. Oncostatic effects in mice.

Authors:  M Hayat; C Bourut; E Chenu; J L Montero; J L Imbach; J S MacDonald; G Mathé
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

2.  CGP 6809, a sugar-containing nitrosourea derivative: pharmacological and physicochemical properties.

Authors:  K Schieweck; J Stanek; P M Kanter; K H Schmidt-Ruppin; M Müller; A Matter
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 3.  New cancer chemotherapy drugs in Europe.

Authors:  G Mathé; L M van Putten
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

4.  DNA crosslinking and cytotoxicity in normal and transformed human cells treated with antitumor nitrosoureas.

Authors:  L C Erickson; M O Bradley; J M Ducore; R A Ewig; K W Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

5.  The cytotoxicity of a 2-chloroethylnitrosourea analog of sarcosinamide in the SK-MG-1 human glioma cell line as a possible indicator for transport.

Authors:  V Skalski; W Feindel; L C Panasci
Journal:  J Neurooncol       Date:  1989-07       Impact factor: 4.130

6.  In vitro comparative studies of the myelotoxicity and antitumor activity of 6-[bis-(2-chloroethyl)-amino]-6-deoxy-D-glucose versus melphalan utilizing the CFU-C and HTSCA assays.

Authors:  P Lazarus; M Dufour; G Isabel; L C Panasci
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

7.  Anti-tumour, toxicological and pharmacokinetic properties of a novel taurine-based nitrosourea (TCNU).

Authors:  B Hartley-Asp; P I Christensson; K Gunnarsson; P O Gunnarsson; G Jensen; J Polacek; A Stamvik
Journal:  Invest New Drugs       Date:  1988-04       Impact factor: 3.850

8.  Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.

Authors:  L C Panasci; D Green; P S Schein
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

9.  D-19575--a sugar-linked isophosphoramide mustard derivative exploiting transmembrane glucose transport.

Authors:  J Pohl; B Bertram; P Hilgard; M R Nowrousian; J Stüben; M Wiessler
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

10.  Antitumor effects of GANU and other nitrosourea derivatives against transplantable leukemias and solid tumors in mice.

Authors:  G Sava; T Giraldi
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.